by CCHR National Affairs Office | Sep 4, 2024
Involuntary commitments to psychiatric facilities have increased over the last decade. Evidence indicates many are unlawful detainments, but facilities bill patients and their insurance providers. A disturbing new exposé, published in the New York Times,...
by CCHR National Affairs Office | Aug 21, 2024
Evidence presented to the U.S. drug regulatory agency alleging sexual assault and suppression of adverse events in clinical trials of ecstasy raises urgent concerns about the safety of patients in psychedelic-assisted psychotherapy. Citizens Commission on Human...
by CCHR National Affairs Office | Aug 13, 2024
The U.S. drug regulatory agency examined evidence presented by the company requesting approval for MDMA (ecstasy) and reports from experts examining that evidence before denying approval for the drug as mental health treatment. A medical journal has just retracted...
by CCHR National Affairs Office | Aug 7, 2024
The Substance Abuse and Mental Health Services Administration should make 988 Lifeline data available so researchers and policymakers can evaluate the effectiveness and appropriateness of the handling of calls, and to ensure callers’ human rights are being respected,...
by CCHR National Affairs Office | Jul 31, 2024
Citing a new report on the success of no-restraint policies in Italy, Citizens Commission on Human Rights calls for mental health care reforms that align with international standards for a human rights-based approach in mental health practices. A new report...
